DelSiTech Ltd is excited to attend and present at Bio€quity Europe 2026, taking place on 4–6 May 2026 in Prague, Czech Republic. Bio€quity Europe is a premier life sciences investment and partnering event focused on company building, strategic collaborations, and financing. DelSiTech’s participation reflects its continued focus on advancing its proprietary silica‑based drug delivery platform and exploring partnering and investment opportunities with our ultra long-acting pipeline on Obesity and Post Operative Pain.
DelSiTech will be represented by Dr. Frederic Dargelas (CCO). Reach out here to book a meeting or connect via LinkedIn.